Professor NG Chi Fai
吴志辉
Professor
MBChB, MD (CUHK), FRCSEd, FCSHK, FRCSEd (Urol), FHKAM (Surgery)

Urology
(852) 3505 2625
ngcfadd this for spam@add this for spamsurgery.cuhk.edu.hk
E-5134-2011
0000-0002-1723-9646

---

Biography
Dr NG Chi Fai, Anthony is Professor of Division of Urology, Department of Surgery. He has research interests in stone diseases and prostate diseases. He has more than 200 peer-reviewed publications and nearly twenty book chapters written over the years.Besides his effort in basic and clinical research, he is also devoted to improve the care of his patients and urology care in Hong Kong and the region.

He has led his team to revolutionise the diagnostic approach and management of prostate cancer in the territory. His research has supported the use of new diagnostic test, Prostate Health Index, in Hong Kong and also Asia to improve the diagnostic yield of prostate biopsy and minimise complications. He is also one of the pioneers in robotic surgery for prostate cancer, which greatly improve the quality of life for these patients. He has performed the first robotic prostatectomy by the new da Vinci SP? system in Asia. He is also leading the robotic training program in our institutes.

He has extensive collaborations with local institutes and also other regional and worldwide centres to facilitate research and care improvement.

Together with the paediatric surgery colleagues, he established the Youth Urological Treatment Centre which provide one-stop service for patients with urological complications secondary to substance abuse. This is the first of the kind to provide wholistic care for these patients.

Prof Ng is also keen in professional training and knowledge transfer. He has founded Asian Urological Surgery Training and Educational Group (AUSTEG) to lead regional training to young urologists in Asia.

He and his team was honoured with Merit team in Outstanding staff and Teams Award 2019 by Hospital Authority.

---

Research Interests
Prostate cancer: epidemiology, diagnosis and treatment
BPH and voiding dysfunction in men
Management of stone disease
Urological complications secondary to substance abuse

---

Additional Information
Cluster service coordinator, NTEC Urology, Dept of Surgery, The Chinese University of Hong Kong
Director SH Ho urology Centre, the Chinese University of Hong Kong
Course Director, Robotic Surgical System Training Programme, the CUHK_ Hong Kong Jockey Club Minimally Invasive Surgical Skill Centre
Co-director, Youth Urological Treatment Centre, The Chinese University of Hong Kong
Council member, the College of Surgeons of Hong Kong
Board member, Urology Board, the College of Surgeons of Hong Kong
Member, Action Committee Against Narcotics (ACAN), Narcotic Division, Hong Kong SAR
Member of Board of Director, Endourology Society
Founding Chairman, Asian Urological Surgery Training and Educational Group (AUSTEG)
International Associate, EAU Section of Urolithiasis (EULIS), European Association of Urology
Core Member, UAA guideline on Urolithiasis

---

Selected Publications
Ng CF, Yee CH, Teoh JYC, Lau B, Leung SCH, Wong CYP, Wong KT, Chu WCW, Yuen J. Effect of Stepwise Voltage Escalation on Treatment Outcomes following Extracorporeal Shock Wave Lithotripsy of Renal Calculi: A Prospective Randomized Study. J Urol. 2019 Nov;202(5):986-993. doi: 10.1097/JU.0344. Epub 2019 Oct 9.
Ng CF, Teoh JY, Chiu PK, Yee CH, Chan CK, Hou SS, Kaouk J, Chan ES. Robot-assisted single-port radical prostatectomy: A phase 1 clinical study. Int J Urol. 2019 Sep;26(9):878-883. doi: 10.1111/iju.14044.
Chiu PK, Ng CF, Semjonow A, Zhu Y, Vincendeau S, Houlgatte A, Lazzeri M, Guazzoni G, Stephan C, Haese A, Bruijne I, Teoh JY, Leung CH, Casale P, Chiang CH, Tan LG, Chiong E, Huang CY, Wu HC, Nieboer D, Ye DW, Bangma CH, Roobol MJ. A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian Settings. Eur Urol. 2018 Nov 2. pii:S0302-2838(18)30842-X. doi: 10.1016/j.eururo.2018.10.047.
Chiong E, Murphy DG, Akaza H, Buchan NC, Chung BH, Kanesvaran R, Khochikar M, Letran J, Lojanapiwat B, Ng CF, Ong T, Pu YS, Saad M, Schubach K, Türkeri L, Umbas R, Vu LC, Williams S, Ye D; ANZUP Cancer Trials Group, Davis ID. Management of patients with advanced prostate cancer in the Asia Pacific region: 'real-world' consideration of results from the Advanced Prostate Cancer Consensus Conference APCCC 2017. BJU Int. 2018 Jul 18. doi: 10.1111/bju.14489.
Ng CF, Luke S, Yee CH, Leung SCH, Teoh JYC, Yuen J. Extracorporeal Shockwave Lithotripsy Could Lead to a Prolonged Increase in the Renal Fibrotic Process of Up to 2 Years. J Endourol. 2018; Mar;32(3):223-229 doi: 10.1089/end.2017.0684.
Hong YL, Yee CH, Tam YH, Wong JH, Lai PT, Ng CF. Management of complications of ketamine abuse: 10 years' experience in Hong Kong. Hong Kong Med J. 2018 Apr;24(2):175-181. doi: 10.12809/hkmj177086.
Chiu PK, Roobol MJ, Nieboer D, Teoh JY, Yuen SK, Hou SM, Yiu MK, Ng CF. Adaptation and external validation of the European randomised study of screening for prostate cancer risk calculator for the Chinese population. Prostate Cancer Prostatic Dis. 2017 Mar;20(1):99-104.
Tsoi TH, Chan CF, Chan WL, Chiu KF, Wong WT, Ng CF, Wong KL. Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers. PLoS One. 2016 Sep 6;11(9):e0162217. doi: 10.1371/journal.pone.0162217.
Wong MC, Goggins WB, Wang HH, Fung FD, Leung C, Wong SY, Ng CF, Sung JJ. Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries. Eur Urol. 2016 Nov;70(5):862-874
Tam YH, Ng CF, Pang KK, Yee CH, Chu WC, Leung VY, Wong GL, Wong VW, Chan HL, Lai PB. One-stop clinic for ketamine-associated uropathy: report on service delivery model, patients’ characteristics and non-invasive investigations at baseline by a cross sectional study in a prospective cohort of 318 teenagers and young adults. BJU Int. 2014 2014 Nov;114(5):754-60.


BACK
BACK